€135.50
4.10% day before yesterday
Xetra, Mar 07, 05:35 pm CET
ISIN
DE0006599905
Symbol
MRK
Index
Sector
Industry

Merck Stock price

€135.50
-4.65 3.32% 1M
-34.40 20.25% 6M
-4.40 3.15% YTD
-21.10 13.47% 1Y
-31.65 18.94% 3Y
+32.60 31.68% 5Y
+37.59 38.39% 10Y
Xetra, Closing price Fri, Mar 07 2025
-5.80 4.10%
ISIN
DE0006599905
Symbol
MRK
Index
Sector
Industry

Key metrics

Market capitalization €58.91b
Enterprise Value €66.77b
P/E (TTM) P/E ratio 21.85
EV/FCF (TTM) EV/FCF 23.15
EV/Sales (TTM) EV/Sales 3.16
P/S ratio (TTM) P/S ratio 2.78
P/B ratio (TTM) P/B ratio 2.08
Dividend yield 1.62%
Last dividend (FY24) €2.20
Revenue growth (TTM) Revenue growth 0.78%
Revenue (TTM) Revenue €21.16b
EBIT (operating result TTM) EBIT €4.53b
Free Cash Flow (TTM) Free Cash Flow €2.88b
Cash position €2.52b
EPS (TTM) EPS €6.39
P/E forward 17.63
P/S forward 2.66
EV/Sales forward 3.02
Show more

Create a Free Account to create an Merck alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Merck Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Merck forecast:

15x Buy
83%
3x Hold
17%

Analyst Opinions

18 Analysts have issued a Merck forecast:

Buy
83%
Hold
17%

Financial data from Merck

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
21,156 21,156
1% 1%
100%
- Direct Costs 8,671 8,671
1% 1%
41%
12,485 12,485
1% 1%
59%
- Selling and Administrative Expenses 3,546 3,546
4% 4%
17%
- Research and Development Expense 2,279 2,279
7% 7%
11%
6,660 6,660
6% 6%
31%
- Depreciation and Amortization 2,134 2,134
14% 14%
10%
EBIT (Operating Income) EBIT 4,526 4,526
3% 3%
21%
Net Profit 2,776 2,776
2% 2%
13%

In millions EUR.

Don't miss a Thing! We will send you all news about Merck directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merck Stock News

AD HOC NEWS
4 days ago
Nach einem schwachen Vorjahr ist es beim Pharma- und Technologiekonzern Merck KGaA DE0006599905 2024 im Tagesgeschäft wieder aufwärts gegangen.
AD HOC NEWS
4 days ago
(In der Überschrift wurde ein Tippfehler behoben: Aufschwung)DARMSTADT - Nach einem schwachen Vorjahr ist es beim Pharma- und Technologiekonzern Merck KGaA DE0006599905 2024 wieder aufwärts gegangen.
AD HOC NEWS
4 days ago
(Im letzten Absatz wir klargestellt, dass es sich um rund 70 rpt 70 Standorte handelt.)DARMSTADT - Nach einem schwachen Vorjahr ist es beim Pharma- und Technologiekonzern Merck KGaA DE0006599905 2024 wieder aufwärts gegangen.
More Merck News

Company Profile

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Head office Germany
CEO Belén López
Employees 62,557
Founded 1995
Website www.merckgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today